Objectives The objective of the present study is to assess the performance of a high-risk
human papillomavirus (HR-HPV) DNA test with individual HPV-16/HPV-18 genotyping as a …

The focus for HPV genotyping has largely been on types 16 and 18, based on their high
prevalence in cervix cancer. However screening is focussed on the detection of high grade …

Background: High-risk human papillomavirus (hrHPV) testing to triage women with minor
cervical lesions generates many referrals. Purpose: To evaluate the accuracy of genotyping …

Objectives There is growing interest in using human papillomavirus (HPV) genotyping as a
risk-based triage approach for women with atypical squamous cells-undetermined …

The effective management of women with human papillomavirus (HPV)-positive, cytology-
negative results is critical to the introduction of HPV testing into cervical screening. HPV …

Background Only clinically validated HPV assays can be accepted in cervical cancer
screening. Objectives To update the list of high-risk HPV assays that fulfil the 2009 …

OBJECTIVE: High-risk (HR) human papillomavirus (HPV) testing is important in cervical
cancer screening for triage to colposcopy. This study evaluated the clinical performance of …

Background Testing for high-risk HPV is more effective in primary cervical cancer screening
than the cytological examination of a Pap smear. Separate genotyping may be useful for …

Cervical cancer screening is presently done by finding abnormal cells in cervical smears (ie,
cervical cytology or Pap smears). However, cervical cytology is not full-proof. Cervical …

Classification of high‐risk HPV types for cervical cancer screening depends on
epidemiological studies defining HPV type‐specific risk. The genotyping tests that are used …